KR20070091746A - Antioxidant of eleutherococcus senticosus maxim. and health nutraceutical containing the same - Google Patents

Antioxidant of eleutherococcus senticosus maxim. and health nutraceutical containing the same Download PDF

Info

Publication number
KR20070091746A
KR20070091746A KR1020060021247A KR20060021247A KR20070091746A KR 20070091746 A KR20070091746 A KR 20070091746A KR 1020060021247 A KR1020060021247 A KR 1020060021247A KR 20060021247 A KR20060021247 A KR 20060021247A KR 20070091746 A KR20070091746 A KR 20070091746A
Authority
KR
South Korea
Prior art keywords
extract
antioxidant
eleutherococcus senticosus
prickly pear
health functional
Prior art date
Application number
KR1020060021247A
Other languages
Korean (ko)
Inventor
박상기
이헌식
박형국
Original Assignee
주식회사 엘지생활건강
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 엘지생활건강 filed Critical 주식회사 엘지생활건강
Priority to KR1020060021247A priority Critical patent/KR20070091746A/en
Publication of KR20070091746A publication Critical patent/KR20070091746A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30Dietetic or nutritional methods, e.g. for losing weight
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/25Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/254Acanthopanax or Eleutherococcus

Abstract

A health functional food containing an antioxidant comprising Eleutherococcus senticosus extract having excellent action on inhibiting free-radical production without any side effect to the body is provided. The food is effectively used in treatment and prevention of oral inflammation, periodontal disease, wrinkle formation, skin cancer, cell killing, rheumatoid arthritis, atopic dermatitis and acne generated by free radicals. An antioxidant comprises Eleutherococcus senticosus extract. A health functional food contains 0.01 to 50% by weight of the Eleutherococcus senticosus extract. The Eleutherococcus senticosus extract is obtained by grinding Eleutherococcus senticosus to 10 to 200 meshes, extracting in a solvent at room temperature, filtering, concentrating at 40 to 50deg.C with a vacuum concentrator, solubilizing with a proper amount of a solvent solution, storing in a chilled state for 24 to 72hr and filtering.

Description

가시오가피 추출물로 된 항산화제 및 이를 함유하는 건강기능식품{Antioxidant of Eleutherococcus senticosus Maxim. and health nutraceutical containing the same}Antioxidant of Prickly Pear Extract and Health Functional Food Containing It {Antioxidant of Eleutherococcus senticosus Maxim. and health nutraceutical containing the same}

본 발명은 항산화제로서의 가시오가피 추출물의 용도 및 이를 함유하는 건강기능식품에 관한 것이다. 더욱 구체적으로, 본 발명은 가시오가피 추출물이 자유 라디칼 생성을 억제시키는 작용이 우수하고 복용 후 혈액 내에서의 항산화력이 증가하는 것을 확인하고, 이러한 자유 라디칼 생성 억제에 의한 항산화제 효과를 갖는 상기 생약추출물의 용도 및 이를 함유하는 건강기능식품을 제공한다.The present invention relates to the use of prickly pear extract as an antioxidant and to a dietary supplement containing the same. More specifically, the present invention confirms that the extract of the thorn oasis is excellent in the action of inhibiting free radical generation and the antioxidant power in the blood increases after taking, and the herbal extract having the antioxidant effect by inhibiting such free radical generation To provide a use and the health functional food containing the same.

자유 라디칼에 대한 이론은 1950년대에 하만(D. Haman)에 의해서 제시되었으며, 근래에 들어서는 학계 뿐만 아니라 일반인들에게서도 관심을 지속적인 관심을 받고 있다. 라디칼이 인체 내에 존재하게 되는 원인은 다양하며, 이 라디칼은 세포를 파괴하거나 피부 진피층의 결합조직을 절단하거나 교차 결합을 일으킴으로써 구강 염증 및 치주질환, 주름 형성, 피부암, 세포살상, 류마티스성 관절염, 아토피성 피부염, 여드름 등 여러 가지 문제를 일으킨다고 알려져 있다. 자유 라디칼은 체액 성 및 세포성 면역계의 작용, 미토콘드리아에서의 ATP 생산 과정 중 전자 전달계, 미엘로퍼 옥사이드(Myeloper Oxide)의 작용, 자외선, 담배, 스트레스, 세균 등에 의해서 생성된다.The theory of free radicals was proposed by D. Haman in the 1950's and has received a lot of attention in recent years not only from academia but also from the general public. There are many causes for radicals to be present in the human body, which cause oral inflammation and periodontal disease, wrinkle formation, skin cancer, cell death, rheumatoid arthritis, by destroying cells, cutting off connective tissue in the skin dermis, or causing cross-linking. It is known to cause various problems such as atopic dermatitis and acne. Free radicals are produced by the action of the humoral and cellular immune systems, by the electron transport system during the production of ATP in the mitochondria, by the action of Myeloper Oxide, ultraviolet light, tobacco, stress, bacteria, etc.

항산화 물질은 동, 식물계에 널리 분포되어 있는데, 과일과 채소에 많은 페놀성 화합물, 플라보노이드, 토코페롤, 비타민 C, 셀레늄과 같은 항산화물질은 지방의 산화를 지연시키거나 방지하며, 암, 심장혈관계 질환 등을 예방, 지연시킴으로써 노화방지에도 중요한 역할을 한다. 식물계에 존재하는 천연 항산화물질인 토코페롤과 비타민 C는 식품, 의약품 및 화장품 등에 널리 이용되고 있다. 유지 또는 유지함유 식품의 산패는 주로 공기 중의 산소와 결합에 의해 일어나는데, 이를 방지하기 위하여 많은 합성 또는 천연 항산화 물질이 개발되어 왔으나, 그 효과와 경제성 때문에 실제로 많이 사용되고 있는 것은 합성 항산화제이다. 합성 항산화제로는 BHT(Butylated Hydroxy Toluene), BHA(Butylated Hydroxy Anisole), Propyl Gallate 등이 있다. 합성 항산화제는 항산화력이 뛰어나고 가격이 저렴하여 상업용 식품에 많이 사용되고 있으나, 인체 부작용 등 안전성에 대한 우려로 그 사용량이 법적으로 규제되어 있다. 토코페롤과 같은 천연 항산화제는 인체에 대하여 안전하기는 하나 단독으로는 산화 연쇄반응 저지 능력이 낮고, 가격이 비싼 단점이 있다. 따라서, 최근에는 보다 안전하고 항산화 효과가 뛰어난 천연 항산화제를 개발하기 위한 연구가 활발히 이루어지고 있다.Antioxidants are widely distributed in the copper and plant systems. Antioxidants such as phenolic compounds, flavonoids, tocopherols, vitamin C, and selenium in fruits and vegetables delay or prevent the oxidation of fats, and cancer, cardiovascular diseases, etc. By preventing and delaying, it plays an important role in preventing aging. Tocopherols and vitamin C, which are natural antioxidants present in the plant kingdom, are widely used in food, medicine, and cosmetics. The rancidity of fats and oils or foods containing oils and fats is mainly caused by the combination with oxygen in the air. To prevent this, many synthetic or natural antioxidants have been developed. Synthetic antioxidants include Butylated Hydroxy Toluene (BHT), Butylated Hydroxy Anisole (BHA), and Propyl Gallate. Synthetic antioxidants are used in commercial foods because of their excellent antioxidant power and low price, but their usage is legally regulated due to concerns about safety such as human side effects. Natural antioxidants, such as tocopherol, are safe for the human body, but have low disadvantages in preventing oxidative chain reactions and are expensive. Therefore, in recent years, researches are being actively conducted to develop safer and more natural antioxidants.

본 발명자들은 상술한 종래기술의 문제점을 해결하기 위해 각종 한방 약재 및 식물 추출물 등 천연물을 대상으로 수 많은 연구와 실험을 거듭한 결과, 가시오가피 추출물이 자유 라디칼 생성을 억제시키는 작용이 매우 우수하고 또한 자유 라디칼에 의해 발생하는 구강 염증 및 치주 질환, 주름 형성, 피부암, 세포살상, 류마티스성 관절염, 아토피성 피부염, 여드름 치료 및 예방에 유효하게 사용될 수 있음을 밝혀내고 이러한 자유 라디칼 생성 억제에 의한 항산화제 효과를 갖는 가시오가피 추출물의 용도 및 이를 함유하는 건강기능식품을 개발하게 되었다.The present inventors conducted a number of studies and experiments on natural products, such as various herbal medicines and plant extracts to solve the above-mentioned problems of the prior art, the effect of inhibiting the free radical generation is very excellent and free Antioxidant effect by inhibiting free radical production, which has been found to be effective in treating and preventing oral inflammation and periodontal disease caused by radicals, wrinkle formation, skin cancer, cell death, rheumatoid arthritis, atopic dermatitis, acne Has been developed for the use of thorny ogapi extract having a health functional food containing the same.

본 발명은 가시오가피 추출물로 된 항산화제에 관한 것이다.The present invention relates to an antioxidant of the barberry extract.

본 발명은 또한 가시오가피 추출물을 항산화제 성분으로 함유하는 건강기능식품에 관한 것이다. The present invention also relates to health functional foods containing the extract of Prickly Pear.

가시오가피는 오가피나무과의 가시오가피나무(Eleutherococcus senticosus Maxim.)의 껍질을 말린 것이다. 알려진 화학 성분으로는 엘레우테로시드라는 배당체를 비롯하여 배당체 성분이 다량 함유되어 있으며, 그 외 정유성분과 플라보노이드 등이 들어있다. 가시오가피는 보약으로 정신 및 육체적 피로와 병후쇠약에 사용되었으며, 히스테리, 당뇨, 동맥 경화증 및 류머티스성 심근염에도 치료 효과가 있다. 가시오가피는 고래로부터 사용되어 온 약재로서, 체내 섭취에 따른 인체 안전성이 이미 확보되어 있으며, 피부 및 점막에 대한 자극도 거의 없는 극히 안전한 식물이다.Prickly Pear is the dried bark of the Eleutherococcus senticosus Maxim. Known chemical components include glycosides, including glycosides called eleuterosides, and other essential oils and flavonoids. It is used as a medicine for mental and physical fatigue and debilitating diseases. It is also effective in treating hysteria, diabetes, atherosclerosis, and rheumatoid myocarditis. Prickly Pear is a medicinal herb that has been used by whales. It is an extremely safe plant that has already secured human safety by ingestion and has little irritation to skin and mucous membranes.

본 발명에서 사용되는 가시오가피 추출물은 다음과 같이 제조할 수 있다. 가시오가피를 건조시켜 생약 분쇄기로 10 내지 200 메쉬 크기로 분쇄한 후, 추출용매를 가하여 상온에서 냉침시킨 후 여과한다. 여과된 추출물을 40~50℃에서 감압 농축기를 이용하여 용매를 완전히 증발시켜 얻은 농축액을 다시 적당량의 용매 용액에 재용해시켜 각 추출물의 농도를 13%(w/v)로 적절히 조절한다. 이 추출물을 24~ 72시간 동안 냉장 보관한 후 여과하여 가시오가피 추출물을 얻는다. 다른 방법으로, 가시오가피를 건조시켜 생약 분쇄기로 10 내지 200 메쉬 크기로 분쇄한 후, 추출용매를 가하여 끓이면서 3~4시간 동안 추출한다. 동일 과정을 재반복하여 얻은 추출액을 혼합한 후 여과하고, 여과된 추출물을 40~50℃에서 감압 농축기를 이용하여 고형분 45~55%(w/v) 농축액을 제조한 후 말토덱스트린을 혼합하고, 혼합액을 분무 건조기(spray dryer)를 이용하여 분말화하여 가시오가피 추출물을 얻는다. 상기 방법에서 추출 용매로는 물, 정제수, 메탄올, 에탄올, 에틸아세테이트, 헥산을 각각 단독 혹은 혼합하여 사용할 수 있다.Prickly pear extract used in the present invention can be prepared as follows. After drying the thorny opi and crushed into 10 to 200 mesh size with a herbal pulverizer, the extraction solvent is added, cooled to room temperature and filtered. The concentrated extract obtained by completely evaporating the solvent using a vacuum concentrator at 40 to 50 ° C. under reduced pressure was redissolved in an appropriate amount of solvent solution, and the concentration of each extract was properly adjusted to 13% (w / v). The extract is stored refrigerated for 24 to 72 hours and then filtered to obtain a thorny ivy extract. Alternatively, the thorns are dried and pulverized to a size of 10 to 200 mesh with a herbal grinder, and then extracted with boiling solvent by extraction for 3 to 4 hours. The extract obtained by repetition of the same process was mixed and filtered, and the filtered extract was prepared using a reduced pressure concentrator at 40 ~ 50 ℃ solid content 45 ~ 55% (w / v) concentrate, and then mixed maltodextrin, The mixed solution is powdered by using a spray dryer to obtain a bark extract. As the extraction solvent in the above method, water, purified water, methanol, ethanol, ethyl acetate and hexane may be used alone or in combination.

본 발명에 따르면 가시오가피 추출물 자체를 항산화제로 사용한다. 따라서 가시오가피 추출물의 농도는 in vitro 실험결과 0.001% 내지 100% 사용 가능한 것으로 나타났다. 하지만 가시오가피 추출물을 이용하여 환제, 정제 또는 연질 캅셀제 형태를 갖는 건강기능식품을 제조하는데 있어서 가시오가피 추출물은 총 중량을 기준으로 0.01~ 50 중량% 사용한다. 가시오가피 추출물을 0.01 중량% 이하로 사용하는 경우에는 항산화제로서의 효능 효과를 기대하기 어렵고, 또한 건강기능식품으로 제조할 경우에는 각각의 제형으로 제조하기 위해서는 적절한 부형제를 반드시 사용 해야 하기 때문에 50 중량% 이상으로 사용하는 경우에는 원하는 제품 제형(환제, 정제, 연질캅셀)으로 제조하는데 어렵다는 문제점이 있다.According to the present invention is used as an antioxidant extract prickly pear extract itself. Therefore, the concentration of Prickly Pear Extract was found to be 0.001% to 100% in vitro . However, in the manufacture of health functional foods having the form of pills, tablets or soft capsules using prickly pear extract, prickly pear extract is used in an amount of 0.01 to 50% by weight based on the total weight. It is difficult to expect the efficacy as an antioxidant when using prickly pear extract in 0.01% by weight or less, and when it is manufactured as a health functional food, an appropriate excipient must be used in order to prepare each formulation by 50% by weight or more. In the case of using as a desired product formulation (pills, tablets, soft capsules) has a problem that it is difficult to prepare.

이하 본 발명을 실시예 및 실험예에 의거하여 구체적으로 설명하지만, 본 발명의 기술적 범위가 이들로 제한되는 것은 아니다.Hereinafter, the present invention will be described in detail based on Examples and Experimental Examples, but the technical scope of the present invention is not limited thereto.

실시예 1. 자유라디칼 소거 효과 확인을 위한 가시오가피 추출물의 제조Example 1 Preparation of Prickly Pear Extract for Confirming Free Radical Scavenging Effect

건조시킨 가시오가피 300g을 생약 분쇄기로 10 내지 200 메쉬 크기로 분쇄한 후, 에탄올 1500ml를 가하여 상온에서 48시간 냉침시킨 후, 와트만 #2 여과지를 이용하여 여과하였다. 여과된 추출물을 45℃에서 감압 농축기를 이용하여 용매를 완전히 증발시켜 얻은 농축액을 다시 적당량의 70%(w/v) 에탄올 수용액에 재용해시켜 각 추출물의 농도가 13%(w/v)이 되도록 하였다. 이 추출물을 48시간 동안 냉장 보관한 후 와트만 #2 여과지를 이용하여 여과하였다. 여과액을 자유라디칼 소거 효과 확인을 위한 가시오가피 추출물로 사용하였다. After drying 300 g of dried thorny thorns into 10 to 200 mesh sizes using a herbal pulverizer, 1500 ml of ethanol was added thereto, and the resultant was cooled for 48 hours at room temperature, followed by filtration using Whatman # 2 filter paper. The concentrated extract obtained by completely evaporating the solvent using a vacuum concentrator at 45 ° C. was redissolved in an appropriate amount of 70% (w / v) ethanol solution so that the concentration of each extract was 13% (w / v). It was. The extract was refrigerated for 48 hours and then filtered using Whatman # 2 filter paper. The filtrate was used as a thorny opiary extract to confirm the free radical scavenging effect.

실시예 2. 동물 시험 및 건강기능식품 제조를 위한 가시오가피 추출물의 제조Example 2 Preparation of Prickly Pear Extract for Animal Testing and Functional Food Preparation

건조시킨 가시오가피 300g을 생약 분쇄기로 10 내지 200 메쉬 크기로 분쇄한 후, 열수 2700ml를 가하여 끓이면서 3~4시간동안 추출을 하였다. 동일 과정을 재반복하여 얻은 추출액을 혼합한 후 와트만 #2 여과지를 이용하여 여과하였다. 여과된 추출물을 45℃에서 감압 농축기를 이용하여 고형분 50%(w/v) 농축액을 제조한 후 말토덱스트린을 150g을 혼합하였다. 혼합액을 분무 건조기(spray dryer)를 이용하여 분말화하였으며, 이 말토덱스트린 혼합 분말을 가시오가피 추출물로 사용하였 다. After drying the dried thorn oak 300g into a herbal mill grinder into 10 to 200 mesh size, 2700ml of hot water was added and extracted for 3-4 hours while boiling. The extract obtained by repeating the same process was mixed and filtered using Whatman # 2 filter paper. The filtered extract was prepared at 45 ° C. using a vacuum concentrator to prepare a solid 50% (w / v) concentrate, followed by mixing 150 g of maltodextrin. The mixed solution was powdered by using a spray dryer, and this maltodextrin mixed powder was used as a extract of prickly pear.

실험예 1. 자유 라디칼 소거 효과Experimental Example 1. Free radical scavenging effect

DPPH(1,1-Diphenyl-2-picryl-hydrazyl)을 이용한 방법을 통하여 라디칼 소거효과를 측정하였다. DPPH 4mg을 메탄올 100ml에 녹여 DPPH 용액을 만들었다. 실시예 1에서 제조한 자유 라디칼 소거 효과 확인용 가시오가피 추출물 시료를 에탄올에 희석하여 적당한 농도로 만들었다. 시료 또는 대조군 1ml와 DPPH 용액 1ml을 잘 섞은 후 37℃에서 30분 정치한 후 516nm에서 흡광도를 측정하였다. 표준품으로는 BHT(Butylated Hydroxytoluene)을 사용하였으며, 대조군으로는 에탄올을 사용하였다. DPPH 법에 의한 항산화력은 다음과 같은 식으로 구하였다.The radical scavenging effect was measured by the method using DPPH (1,1-Diphenyl-2-picryl-hydrazyl). 4 mg of DPPH was dissolved in 100 ml of methanol to make a DPPH solution. Samples of prickly pear extract for free radical scavenging effect prepared in Example 1 were diluted in ethanol to an appropriate concentration. After mixing 1 ml of the sample or the control and 1 ml of the DPPH solution, the mixture was allowed to stand at 37 ° C. for 30 minutes and the absorbance was measured at 516 nm. BHT (Butylated Hydroxytoluene) was used as a standard and ethanol was used as a control. The antioxidant power by DPPH method was calculated as follows.

Figure 112006016097452-PAT00001
Figure 112006016097452-PAT00001

상기 실험결과는 아래 표 1과 같다.The experimental results are shown in Table 1 below.

표 1. DPPH법에 의한 항산화력Table 1. Antioxidant Activity by DPPH Method

시료명Sample Name 농도(%)density(%) 항산화력(%)Antioxidant power (%) 가시오가피 추출물  Prickly Pear Extract 0.010.01 92.692.6 0.0010.001 48.048.0 0.00010.0001 2.62.6 BHT  BHT 0.010.01 82.982.9 0.0010.001 27.627.6 0.00010.0001 00

DPPH법에 의한 라디칼 소거력을 통한 항산화력을 비교한 결과, 가시오가피 추출물의 항산화력이 표준품인 BHT에 비하여 높은 항산화력을 나타내었으며, 또한 0.0001%의 농도에서도 약간의 항산화력을 보였다.As a result of comparing the antioxidant power through radical scavenging power by DPPH method, the antioxidant power of P. edodes extract was higher than that of BHT, which was a standard product, and also showed a slight antioxidant power at a concentration of 0.0001%.

실험예 2. 활성 산소(Superoxide) 생성 억제 효과Experimental Example 2. Inhibitory Effect of Superoxide Generation

전신질환이 없는 건강한 성인으로부터 구연산을 항응고제로 사용하여 채집된 정맥혈액을 1200rpm에서 10분 동안 원심 분리한 후 이중층의 백혈구 농축액을 회수하여 RPMI 1640 배지와 1:1의 비율로 희석하였다. 50ml 원심 분리 용기에 Ficoll-Paque 12ml을 첨가한 후에 희석된 혈액 30ml을 이중층이 되도록 주의 깊게 첨가하여 1600rpm에서 30분 동안 원심 분리한 후에 혈청이 포함된 상층을 제거하고 단핵세포가 함유된 층을 회수하였다. 여기에 다시 3배의 RPMI 1640배지를 첨가하여 800rpm에서 10분 동안 원심분리 시킨 다음 상등액을 버린 후 다시 RPMI 1640배지를 10ml 첨가하여 다음에 800rpm에서 10분 동안 원심 분리한 후에 상등액을 버렸다. 여액에 HBSS(HANKS' BALANCED SALT SOLUTION) 완충용액을 첨가한 후에 0.45ml의 사람 단핵 백혈구를 분주하여 24-웰 프레이트에 106 cell/well 되도록 하였으며, 95% 공기, 5% CO2, 100% 습도 조건하에서 무균적으로 2시간 동안 배양하였다. FMLP((N-Formyl-Met-Leu-Phe)를 10-6 M 되도록 0.05ml 처리하고 37℃에서 15분 동안 배양하여 세포를 자극한 다음에 80μM 되도록 0.1ml 사이토크롬 C (Cytochrome C), 30㎍ 되도록 0.1ml 슈퍼옥사이드 디스뮤타제(Superoxide dismutase), 가시오가피 추출물(실시예 1에서 제조한 자유 라디칼 소거 효과 확인용 가시오가피 추출물)을 적당한 농도가 되도록 0.1ml 첨가하고, 나머지 총 반응액이 0.9ml되도록 HBSS(HANKS' BALANCED SALT SOLUTION)를 첨가한 후 37℃에서 10분간 보온하고 자극 물질인 식균화된 자이모산 A(Zymosan A)를 최종농도 1.3 mg/ml 되도록 0.1 ml을 첨가하고 진탕하면서 37℃에서 90분간 보온한 후에, 4℃에 10분간 넣어 반응을 정지시킨 다음에 4℃, 1500rpm, 10min 동안 원심 분리한 후 상등액을 550nm에서 Optical density를 측정하였다. 대조군으로는 가시오가피 추출물 대신에 HBSS(HANKS'BALANCED SALT SOLUTION)를 사용하였다.Venous blood collected from citric acid as an anticoagulant from a healthy adult without centrifugation was centrifuged at 1200 rpm for 10 minutes, and then the leukocyte concentrate of the bilayer was recovered and diluted 1: 1 with RPMI 1640 medium. After 12 ml of Ficoll-Paque was added to a 50 ml centrifuge vessel, 30 ml of diluted blood was carefully added to make a double layer, followed by centrifugation at 1600 rpm for 30 minutes to remove the upper layer containing serum and recover the mononuclear cell containing layer. It was. After adding three times RPMI 1640 medium again, centrifuged at 800 rpm for 10 minutes, discarded the supernatant, and then again added 10 ml RPMI 1640 medium, and then centrifuged at 800 rpm for 10 minutes, and then discarded the supernatant. After adding HBSS (HANKS 'BALANCED SALT SOLUTION) buffer solution to the filtrate, 0.45 ml of human mononuclear leukocytes were dispensed to make 10 6 cell / well in 24-well plate, 95% air, 5% CO 2 , 100% humidity. Incubated for 2 hours aseptically under conditions. 0.05ml of FMLP ((N-Formyl-Met-Leu-Phe) to 10 -6 M and incubated for 15 minutes at 37 ℃ to stimulate the cells, 0.1ml Cytochrome C, 30 to 80μM 0.1 μg of Superoxide dismutase and prickly pear extract (prickly pear extract for checking the free radical scavenging effect prepared in Example 1) are added to an appropriate concentration, and 0.1 ml of the total reaction solution is 0.9 ml. After HBSS (HANKS 'BALANCED SALT SOLUTION) was added, warmed at 37 ° C for 10 minutes, and 0.1 ml of the stimulating substance, phylated Zymosan A, was added at a final concentration of 1.3 mg / ml and shaken at 37 ° C. After 90 minutes of incubation, the reaction was stopped for 10 minutes at 4 ° C., and then centrifuged at 4 ° C., 1500 rpm for 10 min, and the supernatant was measured for optical density at 550 nm. As a control, HBSS (HANKS ' BALANCED SALT SOLUTI ON) was used.

Superoxide anion의 생성량은 다음 식에 의하여 계산된다.The amount of superoxide anion produced is calculated by the following equation.

Figure 112006016097452-PAT00002
Figure 112006016097452-PAT00002

활성 산소 생성 억제에 의한 항산화력은 다음과 같은 식으로 구하였다.The antioxidant power by the inhibition of active oxygen production was calculated by the following equation.

Figure 112006016097452-PAT00003
Figure 112006016097452-PAT00003

상기 실험 결과는 아래 표 2와 같다.The experimental results are shown in Table 2 below.

표2. 활성 산소 생성 억제에 의한 항산화력Table 2. Antioxidant power by inhibiting free radical production

시료명Sample Name 시료 농도(%)Sample concentration (%) 항산화력(%)Antioxidant power (%) 대조군Control -- 00 가시오가피추출물  Prickly Pear Extract 0.10.1 9292 0.010.01 6565 0.0010.001 1515

수퍼옥사이드의 생성 억제를 통한 항산화력을 비교한 결과, 가시오가피 추출물 0.1% 농도의 시료에서 수퍼옥사이드의 생성을 거의 완전히 억제하는 것으로 나타났으며, 0.001%의 농도에서도 수퍼옥사이드의 생성을 약간 억제하는 것으로 나타났다.As a result of comparing the antioxidant power by inhibiting the production of superoxide, it was found that the production of superoxide was almost completely suppressed in the sample of 0.1% concentration of prickly pear extract, and slightly inhibited the production of superoxide even at the concentration of 0.001%. appear.

실험예 3. 랫드 혈청 내에서의 항산화 효과Experimental Example 3. Antioxidative Effect in Rat Serum

체중량이 180g 내외인 6주령의 랫드를 이용하여 1주간에 걸쳐 가시오가피 추 출물(실시예 2에서 제조한 동물 시험을 위한 가시오가피 추출물)을 강제 경구 투여를 한 후 혈액을 채취하여 그 혈청을 이용하여 실험예 1에서처럼 DPPH를 이용한 자유 라티칼 소거력에 의한 항산화력을 측정하였다.Using a 6-week-old rat with a body weight of about 180 g, blood was extracted by forceful oral administration of prickly pear extract (prickly pear extract for animal testing prepared in Example 2) for 1 week, and then blood was collected and tested using the serum. As in Example 1, antioxidant activity was measured by free radical scavenging activity using DPPH.

체중량이 180g 내외인 6주령 랫드에 대하여 각각 5마리씩 실험군과 대조군으로 군분류를 하였다. 가시오가피 추출물(실시예 2에서 제조한 동물 시험을 위한 가시오가피 추출물)은 0.5% CMC-Na 용액에 용해시켜 각각 200mg/kg, 100mg/kg이 되도록 10mL씩 존대를 이용하여 강제 경구 투여하였다. 대조군으로는 0.5% CMC-Na 용액을 투여하였다.Five rats of 6-week-old rats with body weight of 180 g were grouped into experimental and control groups. Prickly Pear Extract (Prickly Pear Extract for Animal Test Prepared in Example 2) was dissolved in 0.5% CMC-Na solution and forced orally administered by using a zone of 10 mL to be 200 mg / kg and 100 mg / kg, respectively. 0.5% CMC-Na solution was administered as a control.

각 군의 랫드는 실험 시작 전과 시료 복용 1주일 후에 혈액을 500㎕씩을 채취하여 2500rpm에서 원심분리 한 후 상층액만을 취하여 각 군의 혈액 시료로 사용하였다. DPPH를 이용한 혈청 내 항산화력은 실험예 1에서와 동일한 방법을 사용하되 각 시료와 DPPH 용액은 50㎕를 사용하였으며 96 well plate 내에서 흡광도를 측정하였다. 그 결과를 표 3에 나타내었다.Rats of each group collected 500 μl of blood before the start of the experiment and 1 week after the sample was taken, centrifuged at 2500 rpm, and used only the supernatant as a blood sample of each group. Serum antioxidant activity using DPPH was used in the same manner as in Experimental Example 1, but 50 μl of each sample and DPPH solution was used and the absorbance was measured in a 96 well plate. The results are shown in Table 3.

표 3. 랫드 혈청 내에서의 항산화력Table 3. Antioxidant Potency in Rat Serum

시험군Test group 강제 투여 전Before forced administration 1주일 강제 투여 후1 week after forced administration 대조군(비투여군)Control group (non-administered group) 2323 2525 시험군(100mg/kg 투여)Test group (100 mg / kg dose) 2222 4747 시험군(200mg/kg 투여)Test group (200 mg / kg dose) 2727 6868

랫드에 1주일간 가시오가피 추출물을 강제 투여한 후 그 혈액의 항산화력을 측정한 결과, 가시오가피 추출물을 투여한 시험군에서 더욱 높은 항산화력을 나타내었으며, 또한 가시오가피 추출물을 많이 투여할수록 더 높은 항산화력을 보였다.Antioxidant activity of blood was measured after 1 week of forced administration of prickly gingival extract to rats, and the higher antioxidant activity was shown in the test group to which prickly pear extract was administered. .

상기 실험의 결과, 가시오가피 추출물은 자유 라디칼의 생성을 억제하는 효 능이 매우 우수하여 뛰어난 항산화제로써 사용될 수 있음을 확인할 수 있었으며, 이러한 라디칼에 의해 발생하는 구강 염증 및 치주 질환, 주름 형성, 피부암, 세포살상, 류마티스성 관절염, 아토피성 피부염, 여드름 치료 및 예방에 유효하게 사용될 수 있음을 알 수 있다.As a result of the experiment, it was confirmed that the extract of prickly pear skin can be used as an excellent antioxidant because it has an excellent effect of inhibiting the production of free radicals, oral inflammation and periodontal disease caused by these radicals, wrinkle formation, skin cancer, cells It can be seen that it can be effectively used for the treatment and prevention of killing, rheumatoid arthritis, atopic dermatitis, acne.

실시예 3. 가시오가피 추출물을 이용한 환 제형의 건강기능식품의 제조Example 3. Preparation of dietary supplement foods using pill extract

실시예 2에서 얻은 가시오가피 추출물을 이용하여 환제를 제조하였다. 환제는 일반적인 환제 제조방법에 의하여 제조하였으며, 이 방법으로 본 발명의 기술적 범위가 이들로 제한되는 것은 아니다. 가시오가피 추출물 10g, 현미 분말 60g, 꿀 10g과 밀가루 풀 20g을 반죽기로 혼합하고, 다시 2단롤러로 재반죽하여 반죽물을 수득하였다. 수득한 반죽물을 자환기에 적용하여 국수가닥 형태의 반죽물을 수득하고, 각 반죽물이 서로 붙지 않도록 밀가루 분말을 도포하였다. 이어서, 국수가닥 형태의 반죽물을 절단기에 적용하여 환모양으로 절단한 후 이를 환제틀에 적용하여 정환하였다. 정환된 환을 40~65℃로 상승되는 조건에서 건조시키고, 코팅한 후 재건조시켜 환(0.2g 내외 크기)을 제조하였다.Pills were prepared by using the extract of Prickly Pear. Pills were prepared by a general pill manufacturing method, and the technical scope of the present invention is not limited thereto. 10 g of prickly pear extract, 60 g of brown rice powder, 10 g of honey and 20 g of wheat flour paste were mixed with a kneader, and again kneaded with a two-stage roller to obtain a dough. The obtained dough was applied to a magnetic ventilator to obtain noodle-like dough, and flour powder was applied so that each dough did not stick together. Subsequently, the noodle-shaped dough was cut into a ring shape by applying it to a cutter, and then it was applied by applying it to a pill frame. The ring was dried under the conditions of rising to 40 ~ 65 ℃, coated and re-dried to prepare a ring (about 0.2g size).

실시예 4. 가시오가피 추출물을 이용한 연질캅셀 제형의 건강기능식품의 제조Example 4 Preparation of Health Functional Food of Soft Capsule Formulation Using Prickly Pear Extract

실시예 2에서 얻은 가시오가피 추출물을 이용하여 연질캅셀을 제조하였다. 연질캅셀은 일반적인 연질캅셀 제조방법에 의하여 제조하였으며, 이 방법으로 본 발명의 기술적 범위가 이들로 제한되는 것은 아니다.A soft capsule was prepared using the prickly pear extract obtained in Example 2. The soft capsule was prepared by a general soft capsule manufacturing method, and the technical scope of the present invention is not limited thereto.

가시오가피 추출물을 주원료로 하여 항산화 기능에 도움을 줄 수 있는 부원 료로 비타민 C를 소량 사용하였으며, 부형제로는 대두유, 밀랍(황납) 및 레시틴을 사용하였다.A small amount of vitamin C was used as a subsidiary ingredient that can help antioxidant function, and the soybean oil, beeswax (wax) and lecithin were used as the main raw materials.

표 4. 연질캅셀 제형의 조성Table 4. Composition of soft capsule formulation

원료 명Raw material 함량 비(%)Content ratio (%) 함량(mg)Content (mg) 혼합 내용물 (360mg)  Mixed Content (360mg) 가시오가피 추출물Prickly Pear Extract 27.77827.778 100.0100.0 비타민 CVitamin c 22.22222.222 80.080.0 대두유Soybean oil 45.00045.000 162.0162.0 밀납(황납)Beeswax 4.0004.000 14.414.4 레시틴lecithin 1.0001.000 3.63.6 (총계)(sum) 100.000100.000 360.0360.0 연질캅셀 기제 ( 185mg )   Soft capsule base (185mg) 젤라틴gelatin 68.85068.850 글리세린glycerin 21.86221.862 마나톨 7070Manatol 7070 8.1978.197 에틸바닐린Ethylvanillin 0.1640.164 이산화티타늄Titanium dioxide 0.3440.344 식용색소 청색1호Food coloring Blue No. 1 0.0040.004 식용색소 청색3호Food coloring Blue No. 3 0.0280.028 식용색소 적색40호Food coloring Red 40 0.5510.551 (총계)(sum) 100.000100.000

상기 표 4에 나타낸 바와 같이 혼합 내용물을 혼합하여 교반기에서 잘 섞이도록 한 후 연질 캅셀 기제에 주입하여 연질 캅셀을 제조하였다.As shown in Table 4, the mixed contents were mixed and mixed in a stirrer, and then injected into the soft capsule base to prepare a soft capsule.

본 발명에 따르면, 가시오가피 추출물이 인체에 부작용이 없고 자유 라디칼 생성을 억제시키는 작용이 우수하며, 이러한 자유 라디칼 생성 억제에 의한 항산화제 효과를 갖는 상기 생약추출물의 용도가 제공되며, 자유 라디칼에 의해 발생하는 구강 염증 및 치주 질환, 주름 형성, 피부암, 세포살상, 류마티스성 관절염, 아토피성 피부염, 여드름 치료 및 예방에 유효하게 사용될 수 있다.According to the present invention, the thorny opiaceae extract has no side effects on the human body and has an excellent effect of inhibiting free radical generation, and the use of the herbal extract having an antioxidant effect by inhibiting such free radical generation is provided, and is generated by free radicals. Oral inflammation and periodontal disease, wrinkle formation, skin cancer, cytotoxicity, rheumatoid arthritis, atopic dermatitis, acne treatment and prevention can be effectively used.

Claims (4)

가시오가피 추출물로 된 항산화제. As an extract Antioxidants. 가시오가피 추출물을 항산화제 성분으로 함유하는 건강기능식품. Health functional food containing the extract of Prickly Pear as an antioxidant. 가시오가피 추출물을 총 중량을 기준으로 0.01~50 중량% 함유하는 건강기능식품. Health functional food that contains 0.01 ~ 50% by weight of prickly pear extract. 제2항 또는 제3항에 있어서, 환제, 정제 또는 연질캅셀 형태를 갖는 건강기능식품. The health functional food according to claim 2 or 3, which is in the form of pills, tablets or soft capsules.
KR1020060021247A 2006-03-07 2006-03-07 Antioxidant of eleutherococcus senticosus maxim. and health nutraceutical containing the same KR20070091746A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020060021247A KR20070091746A (en) 2006-03-07 2006-03-07 Antioxidant of eleutherococcus senticosus maxim. and health nutraceutical containing the same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020060021247A KR20070091746A (en) 2006-03-07 2006-03-07 Antioxidant of eleutherococcus senticosus maxim. and health nutraceutical containing the same

Publications (1)

Publication Number Publication Date
KR20070091746A true KR20070091746A (en) 2007-09-12

Family

ID=38689363

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020060021247A KR20070091746A (en) 2006-03-07 2006-03-07 Antioxidant of eleutherococcus senticosus maxim. and health nutraceutical containing the same

Country Status (1)

Country Link
KR (1) KR20070091746A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITVA20100074A1 (en) * 2010-10-11 2012-04-12 Cinzia Maiuri COSMECEUTICAL COMPOSITION OF REDUCING, ANTI-AGING, ANTIOXIDANT, FREE ANIMALS AND / OR HYGIENIZATION OF THE BUCCALE APPARATUS.
EP2377558A4 (en) * 2009-01-09 2013-11-20 Snu R&Db Foundation Composition for improving inflammatory disease using abh antigens
US20150306024A1 (en) * 2009-08-14 2015-10-29 Amorepacific Corporation Composition containing a natural extract

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2377558A4 (en) * 2009-01-09 2013-11-20 Snu R&Db Foundation Composition for improving inflammatory disease using abh antigens
US20150306024A1 (en) * 2009-08-14 2015-10-29 Amorepacific Corporation Composition containing a natural extract
ITVA20100074A1 (en) * 2010-10-11 2012-04-12 Cinzia Maiuri COSMECEUTICAL COMPOSITION OF REDUCING, ANTI-AGING, ANTIOXIDANT, FREE ANIMALS AND / OR HYGIENIZATION OF THE BUCCALE APPARATUS.

Similar Documents

Publication Publication Date Title
EP1817017B1 (en) Antioxidant dietary supplement compositions and methods for maintaining healthy skin
RU2523384C2 (en) Phytocomplex of bergamot fruit, method for preparing and using as food additive and in pharmacology
JPWO2006014028A1 (en) Sweet potato stem and leaf extract and use thereof
Sameer et al. Daily consumption of antioxidants:-prevention of disease is better than cure
CN107669731B (en) Skin care composition, application thereof and health product
KR20070091746A (en) Antioxidant of eleutherococcus senticosus maxim. and health nutraceutical containing the same
KR101668357B1 (en) Composition for improving skin conditions and method for improving skin conditions using the same
JP5777209B2 (en) Collagen production promoter and food composition
JP2011195534A (en) Hyaluronic acid production promoter, anti-ageing agent and wrinkle-ameliorating agent
KR102512796B1 (en) Extract of Molokhia with high antioxidant effect, and use thereof
WO2018172436A1 (en) Formulations comprising active agents derived from the plant murraya koenigii
KR102115398B1 (en) Functional food compound having antioxidant property and allergic dermatitis treatment property and method for manufacturing the same
CN102058731B (en) Preparation of chaste tree twig leaf and fruit extract and anti-inflammatory medical application thereof
KR20040006823A (en) A healthful food with anti-oxidative function and manufacturing method thereof
Ordaz-Trinidad et al. Patents on phytochemicals: methodologies of extraction, application in food and pharmaceutical industry
KR20040051784A (en) The use of extracts from Terminalia chebula, Gleditsia japonica, Juglans sinensis as a anti-oxidant
RU2436415C2 (en) Composition of biologically active substances based on betulin with regulated rate of releasing components for reducing degree of alcohol intoxication, preventing and relieving alcohol intoxication and alcohol withdrawal syndrome
KR20050054112A (en) The use of extracts from torreya nucifera, mucuna birdwoodiana and/or eriobotrya japonica as a anti-oxidant
Kalamkar et al. A review on Emblica officinalis gaertn
KR101425047B1 (en) Composition for antioxidant comprising extract or fractions of Rhododendron album Blume as an active ingredient
JP7229767B2 (en) oral composition
KR20120044583A (en) Method for boosting antioxidant activity in aloe extract using irradiation
WO2006001112A1 (en) Hair restorer
WO2005004827A1 (en) Composition for anti-phototoxic effect on skin comprising polyphenol purified from green tea, and ascorbic acid and its derivatives
KR20150061506A (en) Composition comprising γ-oryzanol derived from danmi

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application